Please edit the following text with different wording:
Bevacizumab: there was no clinically significant effect of bevacizumab on the pharmacokinetic parameters of capecitabine or its metabolites in the presence of oxaliplatin.
Bevacizumab: in oxaliplatin presence bevacizumab had no clinically relevant effect on both capecitabine and its metabolite pharmacokinetic parameters.